Stem Point Capital LP Protara Therapeutics, Inc. Transaction History
Stem Point Capital LP
- $312 Billion
- Q2 2025
A detailed history of Stem Point Capital LP transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 1,143,677 shares of TARA stock, worth $3.51 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
1,143,677
Previous 1,190,579
3.94%
Holding current value
$3.51 Million
Previous $5.07 Billion
31.68%
% of portfolio
1.11%
Previous 1.62%
Shares
6 transactions
Others Institutions Holding TARA
# of Institutions
81Shares Held
27.7MCall Options Held
37.2KPut Options Held
65.1K-
Janus Henderson Group PLC London, X04.1MShares$12.6 Million0.01% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA2.14MShares$6.57 Million11.14% of portfolio
-
Blackstone Inc New York, NY1.91MShares$5.86 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$5.53 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.75MShares$5.38 Million3.47% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $34.6M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...